Clinical Trial Detail

NCT ID NCT03397394
Title Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma (ATLAS)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Clovis Oncology, Inc.
Indications

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

ureter transitional cell carcinoma

urethra transitional cell carcinoma

Therapies

Rucaparib

Age Groups: adult senior

No variant requirements are available.